News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Avedro, Inc. Announces FDA Submission for Corneal Cross-linking


3/9/2012 6:44:40 AM

WALTHAM, Mass.--(BUSINESS WIRE)--Avedro, Inc. announced today that the Company submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for its VibeX™ (riboflavin ophthalmic solution) /KXL™ System for the treatment of keratoconus and corneal ectasia following refractive surgery.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES